Ching-Yi Wu Selected Research

Therapeutics

1/2022	Comparative effects of EMG-driven robot-assisted therapy versus task-oriented training on motor and daily function in patients with stroke: a randomized cross-over trial.
1/2022	Development and user experience of an innovative multi-mode stroke rehabilitation system for the arm and hand for patients with stroke.
1/2022	A Pilot Randomized Controlled Trial of Botulinum Toxin Treatment Combined with Robot-Assisted Therapy, Mirror Therapy, or Active Control Treatment in Patients with Spasticity Following Stroke.
1/2020	Treatment Effects of Upper Limb Action Observation Therapy and Mirror Therapy on Rehabilitation Outcomes after Subacute Stroke: A Pilot Study.
1/2020	Predicting clinically significant motor function improvement after contemporary task-oriented interventions using machine learning approaches.
1/2019	Hybrid Rehabilitation Therapies on Upper-Limb Function and Goal Attainment in Chronic Stroke.
1/2019	Responsiveness, Minimal Clinically Important Difference, and Validity of the MoCA in Stroke Rehabilitation.
1/2019	Comparative Assessment of Two Robot-Assisted Therapies for the Upper Extremity in People With Chronic Stroke.
1/2019	The Active Ingredient of Cognitive Restoration: A Multicenter Randomized Controlled Trial of Sequential Combination of Aerobic Exercise and Computer-Based Cognitive Training in Stroke Survivors With Cognitive Decline.
3/2018	Association between monocyte chemoattractant protein-1 -2518 A/G gene polymorphism and the outcome of the nonsurgical periodontal treatment.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ching-Yi Wu Research Topics

Disease

42	Stroke (Strokes) 01/2022 - 05/2009
7	Cognitive Dysfunction 03/2022 - 10/2016
2	Muscle Spasticity (Spastic) 01/2022 - 01/2021
2	Infections 12/2021 - 01/2016
2	Ischemic Stroke 12/2019 - 03/2018
2	Bacterial Infections (Bacterial Infection) 10/2016 - 01/2015
2	Gastroenteritis 08/2015 - 02/2013
1	Coinfection 09/2022
1	Sleep Deprivation 01/2020
1	Neoplasms (Cancer) 12/2019
1	Hemorrhage 03/2018
1	Periodontitis 12/2017
1	Chronic Periodontitis 12/2017
1	Inflammation (Inflammations) 01/2017
1	Breast Neoplasms (Breast Cancer) 01/2016
1	Cerebral Palsy (Spastic Diplegia) 02/2015
1	Communicable Diseases (Infectious Diseases) 01/2015
1	Liver Diseases (Liver Disease) 06/2005
1	Charcot-Marie-Tooth Disease (Peroneal Muscular Atrophy) 03/2004
1	Deafness (Deaf Mutism) 02/2003

Drug/Important Bio-Agent (IBA)

4	serum P-component (CIt)IBA 05/2014 - 05/2009
3	Biomarkers (Surrogate Marker)IBA 03/2018 - 04/2014
2	incobotulinumtoxinA FDA Link 01/2022 - 01/2021
2	Anti-Bacterial Agents (Antibiotics)IBA 10/2016 - 01/2015
2	Proteins (Proteins, Gene)FDA Link 03/2004 - 02/2003
1	CytokinesIBA 09/2022
1	Bacterial DNAIBA 09/2022
1	Botulinum Toxins (Botulinum Toxin)IBA 01/2022
1	Antiviral Agents (Antivirals)IBA 12/2021
1	Viral DNAIBA 12/2021
1	Acyclovir (Aciclovir)FDA LinkGeneric 12/2021
1	epigallocatechin gallate (epigallocatechin-3-gallate)IBA 12/2021
1	Type A Botulinum Toxins (Botox)FDA Link 01/2021
1	TeaIBA 01/2020
1	Coffee FDA Link 01/2020
1	salicylhydroxamic acid (SHAM)IBA 01/2020
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 12/2019
1	butylidenephthalideIBA 12/2019
1	Pharmaceutical PreparationsIBA 12/2019
1	Riboflavin (Vitamin B2)FDA LinkGeneric 12/2019
1	ferric oxide (iron oxide)IBA 12/2019
1	Therapeutic UsesIBA 10/2019
1	Butylated Hydroxytoluene (BHT)IBA 01/2019
1	N 30IBA 01/2019
1	HMGB1 Protein (HMG1)IBA 12/2017
1	beta-thujaplicinIBA 01/2016
1	Phosphatidylcholines (Phosphatidylcholine)IBA 01/2016
1	Liposomes (Liposome)IBA 01/2016
1	Dental MaterialsIBA 01/2016
1	PhosphatidylglycerolsIBA 01/2016
1	Complement System Proteins (Complement)IBA 12/2015
1	Rotavirus VaccinesIBA 08/2015
1	PlasticsIBA 01/2015
1	8-Hydroxy-2'-DeoxyguanosineIBA 04/2014
1	shosaiko-to (TJ9)IBA 06/2005

Therapy/Procedure

26	Therapeutics 01/2022 - 05/2009
10	Activities of Daily Living (ADL) 01/2022 - 04/2010
9	Mirror Movement Therapy 01/2022 - 06/2013
6	Cognitive Training 03/2022 - 10/2016
4	Stroke Rehabilitation 01/2022 - 04/2010
2	Aftercare (After-Treatment) 01/2018 - 06/2014
1	Injections 01/2021
1	Transcranial Direct Current Stimulation 01/2020
1	Neurological Rehabilitation 01/2020
1	Lenses 12/2015
1	Aquatic Therapy 02/2015
1	Home Nursing (Nursing, Home) 02/2013
1	Foot Orthoses 01/2013